Deutsche Bank initiated coverage of Circassia Group with a Hold rating and 250 GBp price target. The analyst says the company specializes in the manufacture of vectors to deliver genetic material using a range of viruses to enhance the disease-fighting capabilities of donor or patient’s cells.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSSPF: